You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 247 No. 17, May 7, 1982 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ARTICLE
 This Article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA

Birth defects and vaginal spermicides

S. Shapiro, D. Slone, O. P. Heinonen, D. W. Kaufman, L. Rosenberg, A. A. Mitchell and S. P. Helmrich

In a cohort study of 50, 282 pregnancies recruited between 1958 and 1965, there were 462 gravidae who used nonmercurial spermicides (mostly nonoxynol-9 (95% confidence limits, 0.6 to 1.6). There were also 889 women who used phenylmercuric acetate (no longer available as a spermicide); the corresponding rate ratio was 0.9 (0.6 to 1.3). Limb reduction deformities, neoplasms, Down's syndrome, and hypospadias did not occur in excess in children exposed to spermicides.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Condom Use by Adolescents
Committee on Adolescence
Pediatrics 2001;107:1463-1469.
ABSTRACT | FULL TEXT  

State-by-State Pharmaceutical Formulations?
Frankel and Furey
NEJM 1993;328:1500-1501.
FULL TEXT  

Male contraception -- a review
Donaldson
The Journal of the Royal Society for the Promotion of Health 1985;105:91-98.
 





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1982 American Medical Association. All Rights Reserved.